Your session is about to expire
← Back to Search
IPN10200 for Upper Limb Spasticity (LANTIMA Trial)
LANTIMA Trial Summary
This trial aims to find the best dose of a drug to safely treat upper limb spasticity in adults.
LANTIMA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLANTIMA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LANTIMA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research endeavor enroll participants over thirty years in age?
"The age restrictions for this clinical trial are 18 years of age and above, with a maximum threshold of 70."
For what therapeutic purposes is dose ranging typically utilized?
"Dose ranging is employed to address urinary incontinence, along with spinal cord injury, botox injections, and overactive bladder syndrome."
Is enrollment for this clinical trial still ongoing?
"Clinicaltrials.gov reports that this clinical trial is actively looking for participants, with the study being added on April 29th 2021 and most recently updated on September 28th 2023."
How many sites are hosting this research endeavor?
"Currently, 42 clinical trial sites are enrolling patients in the study. These locations span from Prague and Hamburg to Mainz and other cities; thus, it is recommended that you find a nearby site for convenience when participating."
How many participants are actively engaged in this trial?
"This medical study requires the enrollment of 209 eligible participants, who can join from a variety of hospitals such as General University Hospital in Prague and Clinic of Neurology in Kansas. Similarly, potential patients may also explore opportunities at University Hospital Hamburg-Eppendorf or Clinic and Polyclinic of Neurology located in Michigan."
Have there been other investigations relating to varied dosages of a particular drug?
"At present, the medical field has 46 active trials exploring dose-ranging. Of these studies, 15 are in Phase 3 and 692 sites host clinical trials on this topic. Most of these research centres are located in Farmington Hills, Michigan."
Does my health profile meet the requirements for participating in this clinical research?
"This trial is currently recruiting 209 adults aged 18-70 with spasticity. To be eligible, patients must meet the following requirements: they should have experienced a stroke or traumatic brain injury at least 6 months prior to enrollment; never received any botulinum toxin treatments (or not within 4 months of Baseline); score ≥2 on Modified Ashworth Scale for injected muscle group; demonstrate an angle of spasticity ≥5° in targeted PTMG; and exhibit complete fingers extension with Angle of arrest at slow speed≥160°, wrist extension≥90° and elbow extension≥160°(as measured by Tard"
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger